Insider Transactions in Q1 2021 at Haemonetics Corp (HAE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
385
-2.41%
|
$46,200
$120.07 P/Share
|
|
Mar 08
2021
|
Jacqueline Scanlan SVP, Global Human Resources |
SELL
Open market or private sale
|
Direct |
107
-2.38%
|
$12,840
$120.07 P/Share
|
|
Feb 04
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
2,671
-25.67%
|
$360,585
$135.92 P/Share
|
|
Feb 04
2021
|
Dan Goldstein VP, Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,433
+22.35%
|
$182,475
$75.25 P/Share
|
|
Feb 04
2021
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
12,180
-46.96%
|
$1,632,120
$134.53 P/Share
|
|
Feb 04
2021
|
Charles J Dockendorff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,180
+31.96%
|
$426,300
$35.5 P/Share
|
|
Feb 04
2021
|
Richard J Meelia Director |
SELL
Open market or private sale
|
Direct |
10,353
-24.42%
|
$1,387,302
$134.64 P/Share
|
|
Feb 04
2021
|
Richard J Meelia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,353
+19.62%
|
$362,355
$35.5 P/Share
|